OTC and neoplasm: For instance, we recently demonstrated the increase in vivo persistence and efficacy of anti-CD33 CAR-T metabolically enhanced by inserting ASS1 and OTC expression domains such that these cells could re-synthesized arginine from citrulline discarded by the tumor cells (114).